Evidence mounts for anti-CGRP treatment in cluster headache

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

During cluster headache attacks, plasma levels of calcitonin gene-related peptide (CGRP) increase, and trigeminal nerve activation leads to pain. A new study shows that CGRP infusion can induce cluster headache attacks in some patients, with important implications for the investigation of CGRP-targeted therapies in cluster headache.

Original languageEnglish
JournalNature Reviews Neurology
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Cluster Headache
Calcitonin Gene-Related Peptide
Trigeminal Nerve
Therapeutics
Pain

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Evidence mounts for anti-CGRP treatment in cluster headache. / Leone, Massimo.

In: Nature Reviews Neurology, 01.01.2018.

Research output: Contribution to journalArticle

@article{097166f2395e4d4fba7e78f44d0eafd5,
title = "Evidence mounts for anti-CGRP treatment in cluster headache",
abstract = "During cluster headache attacks, plasma levels of calcitonin gene-related peptide (CGRP) increase, and trigeminal nerve activation leads to pain. A new study shows that CGRP infusion can induce cluster headache attacks in some patients, with important implications for the investigation of CGRP-targeted therapies in cluster headache.",
author = "Massimo Leone",
year = "2018",
month = "1",
day = "1",
doi = "10.1038/s41582-018-0063-2",
language = "English",
journal = "Nature Reviews Neurology",
issn = "1759-4758",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Evidence mounts for anti-CGRP treatment in cluster headache

AU - Leone, Massimo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - During cluster headache attacks, plasma levels of calcitonin gene-related peptide (CGRP) increase, and trigeminal nerve activation leads to pain. A new study shows that CGRP infusion can induce cluster headache attacks in some patients, with important implications for the investigation of CGRP-targeted therapies in cluster headache.

AB - During cluster headache attacks, plasma levels of calcitonin gene-related peptide (CGRP) increase, and trigeminal nerve activation leads to pain. A new study shows that CGRP infusion can induce cluster headache attacks in some patients, with important implications for the investigation of CGRP-targeted therapies in cluster headache.

UR - http://www.scopus.com/inward/record.url?scp=85053202983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053202983&partnerID=8YFLogxK

U2 - 10.1038/s41582-018-0063-2

DO - 10.1038/s41582-018-0063-2

M3 - Article

C2 - 30143795

AN - SCOPUS:85053202983

JO - Nature Reviews Neurology

JF - Nature Reviews Neurology

SN - 1759-4758

ER -